Hosted on MSN2d
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Healio20h
Lumevoq for LHON yields sustained visual acuity improvements at 5 years in phase 3 trial
A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...
Healthline25d
Understanding Optic Neuritis
These include: anterior ischemic optic neuropathy, when part of your optic nerve is not getting enough blood Leber hereditary optic neuropathy, a type of vision loss that is passed down in ...
WebMD1y
Vitamins by Condition
Considering taking supplements to treat leber hereditary optic neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of leber hereditary optic neuropathy.
Blind Rosemount wrestler inspires classmates and coaches
Rosemount senior Nate Beyer wrestles for the Irish despite being diagnosed with Leber's Hereditary Optic Neuropathy (LHON).
Pharmabiz1d
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Business Wire1mon
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ ® Gene Therapy
GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens ...
GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study
Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/105.bapEywUL.js ...